Overview

Influence of Telmisartan and Lacidipine, Combined or Alone, on QT Interval in Healthy Volunteers

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Assessment of the influence of telmisartan, lacidipine and their combination on the QTC interval of the ECG
Phase:
Phase 1
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Lacidipine
Telmisartan